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The mechanism by which the Parkinson’s disease-related protein a-synuclein (a-syn) causes neurodegene-
ration has not been elucidated. To determine the genes that protect cells from a-syn, we used a genetic
screen to identify suppressors of the super sensitivity of the yeast Saccharomyces cerevisiae expressing
a-syn to killing by hydrogen peroxide. Forty genes in ubiquitin-dependent protein catabolism, protein bio-
synthesis, vesicle trafﬁcking and the response to stress were identiﬁed. Five of the forty genes—ENT3,
IDP3, JEM1, ARG2 and HSP82—ranked highest in their ability to block a-syn-induced reactive oxygen species
accumulation, and these ﬁve genes were characterized in more detail. The deletion of any of these ﬁve genes
enhanced the toxicity of a-syn as judged by growth defects compared with wild-type cells expressing a-syn,
which indicates that these genes protect cells from a-syn. Strikingly, four of the ﬁve genes are speciﬁc for
a-syn in that they fail to protect cells from the toxicity of the two inherited mutants A30P or A53T. This ﬁnding
suggests that a-syn causes toxicity to cells through a different pathway than these two inherited mutants.
Lastly, overexpression of Ent3p, which is a clathrin adapter protein involved in protein transport between
the Golgi and the vacuole, causes a-syn to redistribute from the plasma membrane into cytoplasmic vesicular
structures. Our interpretation is that Ent3p mediates the transport of a-syn to the vacuole for proteolytic
degradation. A similar clathrin adaptor protein, epsinR, exists in humans.
INTRODUCTION
Parkinson’s disease (PD) is a common movement disorder that
affects individuals who are .60 years old (1–3). The disease
is characterized by slowness of movement, resting tremor,
rigidity and disturbances of gait and posture. At a cellular
level, dopamine-producing neurons in an area of the mid-brain
called the substantia nigra pars compacta slowly degenerate,
resulting in a deﬁcit of dopamine. Intracytoplasmic inclusions
termed Lewy bodies are found in the affected neurons, and this
is a deﬁning feature of the disease (4,5). The two main com-
ponents of Lewy bodies are lipids and the protein a-synuclein
(a-syn) (6). The identiﬁcation of a-syn as the main component
of Lewy bodies sparked research into this protein as a possible
cause of PD, and this hypothesis was subsequently reinforced
by discoveries that mutation of a-syn (A30P, A53T or E46K)
causes rare, autosomal dominant forms of PD (7–9) and that
triplication of the a-syn locus causes PD (10). Mutations in
other genes such as PARKIN, DJ-1, PINK1 and LRRK2 also
cause PD (3).
a-Syn is an intrinsically unfolded protein containing 140
amino acid (Mw ¼ 14.5 kDa) that is thought to regulate cell
differentiation, synaptic plasticity and dopaminergic neuro-
transmission. a-Syn binds to lipids (11), inhibits phospho-
lipase D (12) and forms a myriad of differently sized
protoﬁbrils and ﬁbers (13). By unknown mechanisms, it
induces the accumulation of reactive oxygen species (ROS)
(14,15), causes proteasome dysfunction (16,17) and blocks
endoplasmic reticulum (ER)–Golgi trafﬁc (18).
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Advance Access published on September 4, 2008A variety of genetic screens have been conducted using
Caenorhabditis elegans (19,20) and Saccharomyces cerevisiae
(18,21,22) to identify genes that protect cells from a-syn toxi-
city. Having been done in different ways and with different
organisms, not surprisingly, little overlap exists in the different
sets of protective genes that have been reported. One theme,
elucidated using yeast, is that genes involved in lipid meta-
bolism and vesicle trafﬁcking are over represented as suppres-
sors of a-syn toxicity (21,23). In this study, a novel hydrogen
peroxide-based genetic screen was used to identify suppressors
ofthesupersensitivityofyeastcells expressingwild-type(WT)
a-syn to killing by hydrogen peroxide. The ﬁnding that the
cytoplasmic degradation of dopamine by monoamine oxidase
generates hydrogen peroxide, and that the ﬂux of hydrogen per-
oxide is especially high in the Parkinson’s brain (24,25),
reinforces the usefulness of conducting a genome-wide screen
with hydrogen peroxide. Here we report the identiﬁcation of
40 genes that, in high copy, suppress the toxicity of human
WT a-syn. The genes fall into the categories of ubiquitin-
dependent protein catabolism, protein biosynthesis, vesicle
trafﬁcking and the response to stress.
RESULTS
A hydrogen peroxide-based genetic screen identiﬁes
suppressors of WT a-syn toxicity
We previously reported, using a high copy yeast genomic
library to ﬁnd suppressors of the super sensitivity of A30P,
a-syn expressing cells to killing by hydrogen peroxide (22).
This same screen was used herein to identify suppressors of
the super sensitivity of WT a-syn expressing cells to killing
by hydrogen peroxide. The basis of the screen is that a-syn
(WT, A30P or A53T) causes oxidative stress in a variety of
cells (14), including yeast (15), which in turn results in the
accumulation of ROS in the cytoplasm. Because cells expres-
sing a-syn (WT, A30P or A53T) are burdened with endogen-
ous oxidants, they cannot tolerate exogenous oxidants. To
exploit this phenomenon, cells harboring pTF201 (WT
a-syn) and a high copy yeast library were pre-grown in non-
inducing media until mid-log phase and then shifted into indu-
cing media and plated on solid agar plates that contained a
disk of concentrated hydrogen peroxide. Such cells exhibited
a sizeable halo of inhibition (3 cm diameter) surrounding
the peroxide disk where colonies failed to grow (Fig. 1A).
In contrast, cells harboring pTF201 (WT a-syn) and the
library often exhibited colonies within this halo of inhibition
(Fig. 1B). Library plasmids from such colonies were isolated
and sequenced as described in the Materials and Methods
section. Strains and plasmids used in this study are given in
Table 1.
Using this approach, 100 protective library plasmids were
recovered. Because library plasmids contained yeast chromo-
somal fragments, some of the library plasmids could contain
more than one gene. Therefore, both strands from each
protective plasmid were sequenced, and with this sequence
information the identities of genes on each plasmid were
determined using the Saccharomyces Genome Database
(http://www.yeastgenome.org/). Some recovered plasmids
contained more than one gene. Instead of subcloning all of
the genes from the recovered library plasmids, many of the
genes were available in expression vectors from Open Biosys-
tems. In total, we purchased sixty-six 2m expression vectors
(Open Biosystems), which contained the genes of interest
behind the GAL1 promoter (Supplementary Material,
Table S1). To determine which genes conferred protection
against WT a-syn toxicity, plasmids were introduced into
the yeast strain FY23, and ROS accumulation was monitored
using the dye dihydrorhodamine 123 (DHR123) (22). DHR123
is a non-ﬂuorescent cell permanent dye that ﬂuoresces when
oxidized. The basis of this secondary screen was that any
gene that protects against WT a-syn toxicity should decrease
the amount of cytoplasmic ROS and therefore decrease the
amount of DHR ﬂuorescence. Conversely, any gene that
does not protect should not affect the DHR ﬂuorescence.
The ability of the 66 genes, identiﬁed in the hydrogen per-
oxide screen, to inhibit ROS accumulation in cells expressing
WT a-syn was determined. Cells were transformed with
pTF201 (WT a-syn) and with a 2m plasmid (BG1805) con-
taining one of the protective genes. Transformants were
pre-grown in non-inducing media to mid-log phase and then
shifted into inducing media. After 2 h, the DHR123 dye was
Figure 1. A genome-wide screen identiﬁes suppressors of the super sensitivity
of WT a-syn expressing cells to killing by hydrogen peroxide. (A) FY23 cells
transformed with pTF201 (WT a-syn) were plated on SGal2Trp. The halo of
inhibition is due to the concentrated hydrogen peroxide on the disk in the
center of the plate. (B) Suppression of WT a-syn toxicity by a high-copy
yeast genomic library. FY23 cells transformed with pTF201 (WT a-syn)
and a 2m yeast genomic library and plated on SGal2Trp2Leu. The disk in
the center of each plate contained 10 ml of 8–10% hydrogen peroxide.
Plates were incubated for 3 days at 308C. In general, the relatively low trans-
formation efﬁciency of the 2m library resulted in fewer colonies per plate com-
pared with the control plate.
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controls consisted of cells transformed with pTF201 (WT
a-syn) or various control plasmids with no inserts. Fluor-
escence, which correlates with cytoplasmic ROS accumu-
lation, was detected using a standard plate reader.
Figure 2 shows the results from the ROS ﬂuorescence assay.
First, yeast cells expressing WT a-syn (þgal) yielded an ROS
ﬂuorescence signal of 1.5 (+0.2)   10
5 units, whereas yeast
cells with no WT a-syn expression (2gal) yielded an
6-fold smaller ROS ﬂuorescence signal of 2.7 (+0.5)  
10
4 units. Secondly, overexpression of 40 different genes
decreased ROS accumulation by 30–60% (P ,,0.05), com-
pared with cells expressing WT a-syn only, and 24 of these
have a human ortholog. These 24 protective yeast genes
with human orthologs are given in Table 2. Thirdly, over-
expression of several genes decreased ROS accumulation by
10–29%, compared with cells expressing WT a-syn only;
however, we did not focus on these genes because of their
relatively small effect. Fourthly, overexpression of nine
genes had either no effect or slightly increased ROS accumu-
lation, compared with cells expressing WT a-syn only. These
nine genes were categorized as non-protective and were not
evaluated any further. The complete list of genes and
P-values is given in Supplementary Material, Table S1.
Deletion of protective genes enhances wt a-syn toxicity
ARG2, ENT3, IDP3, JEM1 and HSP82 were chosen for a more
detailed analysis. These non-essential genes with human
orthologs were chosen because four of them, ARG2, ENT3,
IDP3 and JEM1, conferred the greatest protection against
WT a-syn-induced ROS, and because HSP82 encodes for a
ubiquitous chaperone (Hsp90p) that, in yeast, is required for
pheromone signaling and negative regulation of heat shock
factor, Hsf1p (26). Arg2p is a mitochondrial enzyme that
catalyzes the ﬁrst step in the biosynthesis of ornithine, which
is a precursor of arginine (27). Ent3p is involved in clathrin
recruitment and protein transport between the trans-Golgi
network (TGN) and the vacuole (28). Idp3p is a peroxisomal
variant of the enzyme isocitrate dehydrogenase (29). Jem1p is
a DnaJ-like chaperone that localizes to the ER and is required
for nuclear membrane fusion during mating (30).
Given that these ﬁve genes in high copy suppressed the
toxicity of WT a-syn, we reasoned that the deletion of any of
them should enhance the toxicity of WT a-syn. Figure 3
shows a viability assay in which the ﬁve haploid deletion
strains and the parental wild-type haploid strain KT2253 were
transformed with WT a-syn (pJL101) or a control plasmid
with no insert (pJL100), serially diluted and spotted on sucrose
and galactose plates. In all cases, without WT a-syn expression
(2gal), growth of cells that contained the WT a-syn plasmid
resembled that of cells containing the control plasmid. In con-
trast, the ﬁve haploid deletion strains (ent3D, idp3D, jem1D,
arg2D and hsp82D) expressing WT a-syn grew much more
slowly than the deletion strains harboring the control plasmid
(þgal). The ﬁve haploid deletion strains expressing WT a-syn
also grew much more slowly compared with the wild-type
strain (KT2253) expressing WT a-syn (þgal). No appreciable
difference in growth was observed for the wild-type strain
(KT2253) expressing WT a-syn (þgal) versus the control
plasmid with no insert (þgal), indicating that cells can tolerate
one copy of WT a-syn. The combined results demonstrate that
the deletion of these various genes enhances the toxicity of
WT a-syn and suggests a speciﬁc protective function of the
various gene products.
The ﬁve deletion strains ent3D, idp3D, jem1D, arg2D and
hsp82DexpressingWTa-synwerealsotestedforROSaccumu-
lation and for complementation of any ROS increase by
expressionofthecorrespondinggene.Similartotheexperiment
shown in Figure 2, cells were pre-grown in non-inducing media
Table 1. Yeast strains and plasmids
Strains
FY23 MATa ura3-52 trp1D63 leu2D1
KT2253 MATa his3D1 leu2D0 met15D0 ura3D0
arg2D MATa his3D1 leu2D0 met15D0 ura3D0 kan
r::arg2
ent3D MATa his3D1 leu2D0 met15D0 ura3D0 kan
r::ent3
hsp82D MATa his3D1 leu2D0 met15D0 ura3D0 kan
r::hsp82
idp3D MATa his3D1 leu2D0 met15D0 ura3D0 kan
r::idp3
jem1D MATa his3D1 leu2D0 met15D0 ura3D0 kan
r::jem1
Plasmids
pRS313 Low copy CEN HIS3 ARS Amp
r ATCC
pRS314 Low copy CEN TRP1 ARS Amp
r ATCC
pHY114-WT GAL1 promoter GFP-WT a-syn in pRS314 (15)
pTF200 GAL1 promoter in pRS314 (15)
pTF201 GAL1 promoter WT a-syn in pRS314 (15)
pTF202 GAL1 promoter A30P a-syn in pRS314 (15)
pTF203 GAL1 promoter A53T a-syn in pRS314 (15)
pJL100 GAL1 promoter in pRS313 This study
pJL101 GAL1 promoter WT a-syn in pRS313 This study
pJL102 GAL1 promoter GFP in pRS313 This study
pJL103 GAL1 promoter GFP-WT a-syn in pRS313 This study
pJL200 2m URA3 Amp
r GAL1 promoter This study
pARG2
a 2m URA3 Amp
r GAL1 promoter ARG2 Open Biosystems
aSixty-six 2m plasmids, which contained the 66 genes listed in Supplementary Material, Table S1, were purchased from Open Biosystems. Open
Biosystems calls these plasmids BG1805. We refer to them by the gene name.
3786 Human Molecular Genetics, 2008, Vol. 17, No. 23until mid-log phase and then shifted into inducing media. The
ROS signal was measured after 3 h in inducing media. Each
strain was transformed with pJL101 (WT a-syn) and a 2m
plasmid (Open Biosystems) with the gene of interest or
pJL200 (empty 2m control plasmid) (Table 1).
Figure 4 shows the results from the rescue experiments.
First, the control strain KT2253 expressing WT a-syn
(pJL101) and harboring a 2m empty plasmid (pJL200)
yielded an ROS signal of 154 675+2436 units. In non-
inducing media, this value decreased 84% to
25 179++895 units. Secondly, arg2D, ent3D, hsp82D,
idp3D and jem1D deletion strains expressing WT a-syn
each exhibited an ROS signal greater than the control strain.
For example, arg2D cells expressing WT a-syn exhibited an
ROS signal of 203 971+3699 units, which is a 32% increase
compared with the control strain (154 675!203 971). The
percentage increases in ROS signal compared with the WT
control strain were 32% (arg2D), 65% (ent3D), 21%
(hsp82D), 62% (idp3D) and 37% (jem1D). This assay demon-
strated that the deletion of genes that protect against WT
a-syn toxicity indeed signiﬁcantly increased the accumulation
of ROS. Thirdly, expression of the gene of interest blocked
accumulation of ROS, as expected. For example, arg2D
cells expressing WT a-syn exhibited an ROS signal of
203 971+3699 units, whereas the same cells but with
ARG2 added back (pARG2) exhibited a 69% decrease in
ROS signal to 62 690++680 units. On average, adding
back the gene of interest in high copy caused a 67% decrease
in ROS accumulation in the various deletion strains expres-
sing WT a-syn. The combined results provided further
support that these ﬁve genes protect cells from WT a-syn
toxicity.
Figure 2. ROS ﬂuorescence assay of transformants with 66 yeast genes identiﬁed in the hydrogen peroxide screen as potential suppressors of WT a-syn toxicity.
The y-axis is the ﬂuorescence signal; the x-axis gives the gene name. The FY23 strain was transformed with pTF201 (WT a-syn) and pBG1805 (Open Biosys-
tems 2m plasmid with gene of interest) (see Supplementary Material, Table S1). Cells were pre-grown in sucrose drop out media to mid-log phase and then
transferred into inducing media and incubated for 3 h at 308C. The DHR123 dye (5 mg/ml) was added after 2 h in inducing media. The cells were washed
several times in phosphate-buffered saline (PBS) and resuspended in PBS before measuring the ROS ﬂuorescence signal. The excitation and emission wave-
lengths were 485 and 535 nm, respectively. As a control, FY23 was transformed with the pTF201 (WT a-syn), and these cells were treated identically to
those described above. The ROS signal from these cells was 152 236+15 177 and 27 382+4710 units of ﬂuorescence in inducing and non-inducing
media, respectively. Note that FY23 cells transformed with pTF201 and pJL200 (empty vector) yielded 154 675+2436 and 25 179+895 units of ﬂuorescence
in inducing media and non-inducing media, respectively. Other empty vector controls (pTF200 or pTF200 and pJL200) are also shown. Values for the 24 genes
with human orthologs are shown in color (magenta and red); values for the 5 genes that were characterized in more detail are shown in red.
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accumulation in cells expressing A30P or A53T
A recent study showed that WT a-syn and A53T, but not
A30P, transit through the classical secretory pathway in
yeast and target to the plasma membrane (31), whereas
another study showed that the yeast gene YPT1 is a high
copy suppressor of the toxicity of WT a-syn and A53T but
not of A30P (18). In light of these ﬁndings, we hypothesized
that ARG2, ENT3, IDP3, HSP82 and JEM1 would protect
cells from WT a-syn and A53T, but not A30P. We thus
tested whether these ﬁve genes in high copy would protect
cells from ROS induced by these two inherited a-syn
mutants. The other inherited mutant, E46K, was not evaluated.
We have previously shown that A30P and A53T cause ROS
accumulation in yeast (15). Cells were transformed with plas-
mids for WT a-syn (pTF201), A30P (pTF202) or A53T
(pTF203) and with an Open Biosystems plasmid containing
one of the ﬁve genes of interest, pre-grown in non-inducing
media to mid-log phase, shifted into inducing media for 3 h,
and assayed for ROS accumulation using DHR123. Matched
controls were identically treated cells expressing WT a-syn
but without the gene of interest in high copy. The bars in
Figure 5 represent the ratio of the two signals: 1 indicates
no decrease in ROS, ,1 indicates a decrease in ROS and
.1 indicates an increase in ROS.
ARG2, ENT3, HSP82, IDP3 and JEM1 in high copy signiﬁ-
cantly blocked ROS in cells expressing WT a-syn (Fig. 5A).
On average, high copy ARG2, ENT3, HSP82, IDP3 and
JEM1 resulted in a 50–60% decrease in ROS accumulation.
Strikingly, ARG2, ENT3, HSP82 and IDP3 in high copy had
no protective effect on cells expressing A30P or A53T, i.e.
for these samples the normalized ROS signal was  1. JEM1
in high copy produced a slight decrease in ROS accumulation
in cells expressing A30P (S¼ 0.81+0.09), whereas no
appreciable decrease in ROS accumulation was observed for
cells expressing A53T. We conclude that although the three
a-syns (WT, A30P and A53T) each produce oxidative stress
in cells, the pathobiology of these three a-syns must differ
(see ‘ENT3 and the vacuole’ in the Discussion section).
To complement the above ROS experiments, western blot
analysis was conducted to assess the expression levels of the
various a-syns (WT, A30P or A53T) in the FY23 strain over-
expressing Arg2p, Ent3p, Hsp82p, Idp3p or Jem1p. A mono-
clonal antibody that binds to each of the three forms of
a-syn was used to visualize a-syn. Pgk1p was used as a
loading control. The results are shown in Figure 5B.
First, consider the western blot of cells overexpressing
Arg2p and expressing WT a-syn, A30P or A53T (Fig. 5B;
lanes 1–3). The bands due to WT a-syn (lane 1) and A30P
(lane 2) at 14.5 kDa have similar intensities; thus, it may be
inferred that the expression levels of these two a-syns are
very similar. In contrast, cells overexpressing Arg2p and
expressing A53T display an intense band at 54 kDa and a
less intense band at 39 kDa, which we assign to aggregated
or modiﬁed A53T. Secondly, in three of the ﬁve experiments
with genes in high copy (ARG2, HSP82 and IDP3), the A53T
protein migrated as three species, i.e. 26, 39 and 54 kDa (lanes
3, 9 and 12). The intensities of these three A53T bands are
greater than the intensity of the bands at 14.5 kDa due to
monomeric a-syn. The results suggest that under some con-
Table 2. Yeast genes with human orthologs that suppress WT a-syn toxicity
Gene
ENT3 Vesicle trafﬁcking (Golgi–vacuole)
IDP3 Isocitrate dehydrogenase (peroxisomal variant)
JEM1 DnaJ-like ER membrane protein
ARG2 Mitochondrial enzyme in arginine synthesis
YDR352w PQ-loop protein




CIN2 Tubulin folding factor
RPT5 One of six ATPases of the 19S regulatory particle of the 26S
proteasome
RPL19b Protein component of the large (60S) ribosomal subunit
CTF3 Outer kinetochore protein; may bind the kinetochore to spindle
microtubules
ARX1 Shuttling pre-60S factor; involved in the biogenesis of ribosomal
large subunit biogenesis
CSR1 Phosphatidylinositol transfer protein with a potential role in lipid
turnover
RTG1 Transcription factor (bHLH) involved in interorganelle
communication between organelles
NAM7 ATP-dependent RNA helicase of the SFI superfamily,
SEC61 Retrograde transport of misfolded proteins out of the ER
GPD1 NAD-dependent glycerol-3-phosphate dehydrogenase, key
enzyme of glycerol synthesis
RPO31 RNA polymerase III subunit C160, part of core enzyme
GLG1 Self-glucosylating initiator of glycogen synthesis
NGL3 Putative endonuclease
SPO1 Meiosis-speciﬁc protein with similarity to phospholipase B
YDL025c Putative protein kinase, potentially phosphorylated by Cdc28p
Figure 3. Growth properties of cells expressing WT a-synuclein. The effect of
WT a-synuclein expression on the growth of ﬁve deletion strains (ent3D,
idp3D, jem1D, arg2D and hsp82D) and the WT control strain KT2253 was
evaluated. These strains were transformed with pJL101 (WT a-syn) or
pJL100 (empty vector) and spotted in successive 10-fold serial dilutions on
solid sucrose and solid galactose plates and incubated for 3 days at 308C.
Experiments were repeated three times with similar results.
3788 Human Molecular Genetics, 2008, Vol. 17, No. 23ditions A53T aggregates accumulate in cells compared with
the other two a-syns (WT and A30P). A53T indeed rapidly
forms large inclusions when expressed in yeast (15,32).
Thirdly, in one case, speciﬁcally, for cells overexpressing
Ent3p, the WT a-syn protein migrated as three high molecular
mass species (26, 39 and 54 kDa) (lane 4), whereas A30P and
A53T migrated as monomers (lanes 5 and 6). Note that oligo-
meric forms of WT a-syn have been previously detected using
the yeast model (33). Overall, the western blot results demon-
strate that a-syn (WT, A30P and A53T) is indeed expressed in
the presence of the various genes in high copy, and that, in
general, the A53T variant may accumulate to a greater
extent than the other two a-syns. However, the ﬁve genes
speciﬁcally protect only against ROS in cells expressing WT
a-syn (Fig. 5A).
Ent3p alters the localization of GFP-WT a-syn
Given that ENT3 was the strongest suppressor and that it has a
human ortholog (epsinR), we sought to determine the effect of
Ent3p overexpression on the localization of GFP-WT a-syn
by ﬂuorescence microscopy. Yeast cells expressing GFP-WT
a-syn displayed bright green ﬂuorescence around the perimeter
ofthecellsat3and12 hofincubationininducingmedia(Fig.6;
upperpanels).Thisresultisconsistentwiththeassociationofthe
GFP-WT a-syn protein with the plasma membrane, as has been
reported by numerous groups (15,31,32). Identically treated
cells expressing GFP-WT a-syn, but also overexpressing
Ent3p, displayed a similar membrane association of GFP-WT
a-syn at 3 h (Fig. 6; lower left panel), whereas cells displayed
numerous GFP-WT a-syn inclusions (puncta) at 12 h (Fig. 6;
lower right panel). For these cells overexpressing Ent3p, it is
noteworthy that only 0.5% (n ¼ 714) of the cells displayed
one or more GFP-WT a-syn inclusions at 3 h, whereas 84%
(n ¼ 1562 cells) of the cells displayed one or more GFP-WT
a-syninclusionsat12 h.ApossibleroleofENT3indetoxifying
yeast cells of WT a-syn is considered in the Discussion section.
DISCUSSION
We have identiﬁed 24 yeast genes with human orthologs that
suppress the toxicity of WT a-syn. The genes fall into several
categories, including ubiquitin-dependent protein catabolism,
protein biosynthesis, vesicle trafﬁcking and the response to
stress.
Some of the genes we identiﬁed are similar to genes identi-
ﬁed in an earlier genetic screen using S. cerevisiae. The pio-
neering study by Willingham et al. (21) used the yeast
collection of 4852 haploid mutants containing deletions of
non-essential genes to identify those mutants that were sick
or synthetically lethal with WT a-syn. Although no overlap
exists between the 86 genes identiﬁed by Willingham et al.
and the 40 genes identiﬁed by us, intriguing similarities
should be noted. They identiﬁed PEX2 and PEX8, which
encode for peroxisome biogenesis proteins. We identiﬁed
IDP3, which is an enzyme that functions to maintain high
levels of the key co-factor NADPH in the interior of peroxi-
somes (see ‘IDP3 and the b-oxidation of lipids’ section).
Figure 4. ROS accumulation in ent3D, idp3D, jem1D, arg2D and hsp82D deletion strains expressing WT a-syn. The ﬂuorescence assay using the dye DHR123
was used to measure the ROS accumulation in WT a-synuclein expressing cells after 3 h incubation in inducing media at 308C. The WT haploid strain KT2253
transformed with pJL101 (WT a-syn) and pJL200 (empty vector) exhibited an ROS signal of 154 675+2436 and 25 179+895 in inducing media (þgal) and
non-inducing media (2gal), respectively. KT2253 transformed with two empty vectors (pJL100 and PJL200) (þgal) exhibited an ROS signal of 19 763+349.
The arg2D strain transformed with pJL101 (WT a-syn) and pJL200 (red bar) or pARG2 (2m Open Biosystems plasmid containing ARG2) (blue bar) were treated
identically to the WT control strain, and ROS was measured at 3 h. The ROS signal from the arg2D strain transformed with two empty vectors (pJL100 and
pJL200) is represented by the green bar. The other four deletion strains were prepared and analyzed in the same way as arg2D.
Human Molecular Genetics, 2008, Vol. 17, No. 23 3789Willingham et al. identiﬁed four genes—SAC2, VPS24, VPS28
and VPS60—that are involved in protein sorting in the late
Golgi, sorting to the prevacuolar endosomes and for protein
sorting and trafﬁcking to the vacuole, respectively. We ident-
iﬁed ENT3, which is involved in protein transport between the
trans-Golgi network (TGN) and the vacuole (see ‘ENT3 and
the vacuole’ section). These combined results show the
importance of vesicle-trafﬁcking genes and peroxisomal
genes as modiﬁers/regulators of a-syn toxicity.
Someofthegenesweidentiﬁedaresimilartogenesidentiﬁed
inarecentgeneticscreenusingC.elegans.Onestudy(19)ident-
iﬁed a molecular chaperone of the DnaJ superfamily (T05C3.5,
dnj-19) and genes associated with cargo transport and
membrane trafﬁcking (C54H2.5, sft-4 and F57B10.5, Emp24/
gp25L/p24). We also indentiﬁed a molecular chaperone of the
DnaJ superfamily (JEM1) and one gene associated with cargo
transport and membrane trafﬁc (ENT3). Another study using
C. elegans (20) identiﬁed Hsp90 as a suppressor of WT a-syn
toxicity; we identiﬁed the same gene.
Arg2
In yeast, Arg2p, which is located in the mitochondrial matrix,
catalyzes the ﬁrst step in the biosynthesis of the arginine
Figure 5. (A) ARG2, ENT3, HSP82, IDP3 and JEM1 in high copy fail to suppress the toxicity of A30P or A53T. The ﬂuorescence assay using DHR123 was used
to measure the ROS accumulation in cells expressing various a-synucleins (WT, A30P or A53T). For example, the FY23 strain was transformed with pARG2
(2m plasmid with ARG2) and with pTF201 (WT a-syn), pTF202 (A30P) or pTF203 (A53T). Matched controls consisted of the FY23 strain transformed with
pTF201 (WT a-syn), pTF202 (A30P) or pTF203 (A53T). Cells were pre-grown in non-inducing media, shifted into inducing media and then incubated for 3 h.
The DHR123 dye (5 mg/ml) was added after 2 h in inducing media, and the ROS signal was measured 1 h later. Prior to measuring the ﬂuorescence signal, the
cells were washed and resuspended in PBS. Each bar in the graph represents the ratio: average ROS signal (multi-copy gene)/average ROS signal (single copy
gene). A value of 1 indicates no protection; a value ,1 indicates a decrease in ROS; and a value .1 indicates an increase in ROS. The average signals were
obtained from triplicate samples recorded on three different days. Error bars were determined by to the method described in Bevington (64). (B) Western blot
analysis of a-syn expression in the cultures as shown in (A). Lysates were prepared and then subjected to SDS–PAGE followed by western blot analysis. The
cell-signaling monoclonal antibody against a-syn was used to visualize the three a-syns in yeast cells overexpressing the ﬁve genes of interest. The loading
control was the yeast protein Pgk1p. Identical amounts of protein were loaded per well.
3790 Human Molecular Genetics, 2008, Vol. 17, No. 23precursor ornithine (27,34,35). Once synthesized, ornithine is
transported into the cytosol, where it is converted by several
enzymes into arginine. The transcription of the genes involved
in arginine biosynthesis, including ARG2, is governed by the
evolutionarily conserved transcription factor Gcn4p (36,37).
It is noteworthy that Gcn4p also plays an essential role in
the unfolded protein response (UPR) in yeast and higher
eukaryotes. Speciﬁcally, Gcn4p and its activator Gcn2p are
required for induction of a majority of UPR target genes
during ER stress (38). WT a-syn transits through the classical
secretory pathway in yeast and mammalian cells and induces
ER stress and activates the UPR (31,39). We therefore
reason that in response to a-syn-induced ER stress Gcn4p acti-
vates numerous UPR genes that serve to counteract such stress
and propose that one of these genes is ARG2. We also point
out that a recent screen of the S. cerevisiae yeast deletion col-
lection for mutants that affect the telomere length identiﬁed
150 candidate genes not previously known to affect the telo-
mere length, one of these mutants was arg2D (40). Telomeres
are shorter in the arg2D strain compared with a WT strain.
How arginine metabolism affects telomere length and a-syn
toxicity is not known.
In mammals, NAGS synthesizes carbamyl phosphate
synthetase and controls the formation of citrulline during the
urea cycle (27). The urea cycle functions to remobilize nitro-
gen atoms from arginine (a nitrogen-storage amino acid),
which may be important for cell rescue during oxidative
stress (41), and perhaps even ER stress.
Chaperones
HSP82 and JEM1 were identiﬁed as high copy suppressors
of the toxicity of WT a-syn. HSP82 encodes for a ubiquitous
chaperone Hsp90 that, in yeast, is required for pheromone sig-
naling and the negative regulation of heat shock factor (Hsf1p)
(42,43). Hsp90 binds to transcription factors, kinases and
other chaperones to regulate various signaling pathways (44).
The overexpression of Hsp90 could protect yeast from the tox-
icity of WT a-syn in at least two different ways. First, Hsp90
might bind to WT a-syn, and this complexation could prevent
the formation of toxic oligomers of WT a-syn (45). Note that
the overexpression of HSP70 has been shown to protect against
ROS induced by the expression of WT a-syn (15,25,46).
Secondly, perhaps, Hsp90 overexpression protects cells from
WT a-syn because of its ability to bind kinases (44). In some
but not all models phosphorylation of WT a-syn at serine 129
enhances the toxicity of this protein (47–49). Perhaps, Hsp90,
when overexpressed, binds to the kinase or kinases that
phosphorylate WT a-syn, and this complexation prevents the
phosphorylation of WT a-syn and thus protects cells from the
toxic phosphorylated form of the protein.
The Jem1p protein is a member of the DnaJ superfamily,
and it is located in the ER. DnaJ proteins bind unfolded pro-
teins and deliver them to Hsp70 chaperones for holding or
refolding (50). Yeast express a variety of different DnaJ pro-
teins; these isoforms may reside in different cellular compart-
ments and bind different substrates. Given that WT a-syn
transits through the secretory pathway in yeast and human
cells and is known to cause ER stress (31,39), as mentioned
above, perhaps Jem1p functions to ameliorate the ER stress
caused by WT a-syn.
IDP3 and the b-oxidation of lipids
Saccharomycescerevisiaeexpressmitochondrial(Idp1p),cyto-
solic (Idp2p) and peroxisomal (Idp3p) isoforms of isocitrate
dehydrogenase (29,51). Two classes of this enzyme exist: one
class uses NAD
þ as an electron acceptor, whereas the other
class uses NADP
þ as an electron acceptor. Peroxisomal Idp3p
is a NADP
þ-dependent isocitrate dehydrogenase that oxidizes
isocitrate to yield a-ketoglutarate, NADPH and CO2. In yeast
and many other organisms, the b-oxidation of lipids is conﬁned
to peroxisomes, whereas in mammals it occurs in peroxisomes
and mitochondria. The oxidation of unsaturated fatty acids in
yeast peroxisomes requires several enzymes, one of which is
the NADPH-dependent 2,4-dienoyl-CoA reductase. As lipid
molecules are oxidized within peroxisomes, the level of
NADPH gradually decreases to a threshold concentration
under which lipid oxidation ceases, unless NADPH is replen-
ished. However, because the peroxisomal membrane is
impermeable to pyrimidine nucleotides, there is no way to
replenish NADPH. It was thus proposed that Idp3p replenishes
peroxisomal NADPH through its oxidation of isocitrate (29);
thus, IDP3 is linked to lipid metabolism.
Human cells also express mitochondrial, cytosolic and per-
oxisomal isoforms of isocitrate dehydrogenase. Human PICD
was recently identiﬁed as an ortholog of yeast IDP3 (52). The
PICD protein is 59% identical to Idp3p, it catalyzes the oxi-
dative decarboxylation of isocitrate and it localizes to the
cytosol and peroxisomes of human and rat liver cells. Similar
to yeast, PICD probably replenishes peroxisomal pools of
NADPH, which is a necessary co-factor for lipid oxidation
(52). Given that cells expressing WT a-syn accumulate lipid
droplets (32), perhaps IDP3 and PICD help cells metabolize
accumulating lipids.
Figure 6. ENT3 alters the localization of WT a-syn. The KT2253 strain was
transformed with pJL103 (GFP-WT a-syn) and pENT3 or the empty vector
pJL200. Cells were pre-grown in non-inducing media until mid-log phase,
washed and resuspended in inducing media, and incubated for 12 h at 308C.
Cells were visualized by ﬂuorescence microscopy at 3 and 12 h as discussed
in the Materials and Methods section. The top row shows cells expressing
GFP-WT a-syn with pJL200 control plasmid; the bottom row shows cells
expressing GFP-WT a-syn with ENT3 in high copy (pENT3).
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Ent3p mediates protein transport from the TGN to the vacuole
in S. cerevisiae (28,53–56). Ent3p and its human counterpart
epsinR (57) appear to be accessory proteins that interact with
the clathrin adapter proteins AP-1/GGAs, which are proteins
involved in clathrin-mediated anterograde and retrograde
protein transport between the Golgi and endosomes. Ent3p
and epsinR contain an amino-terminal phosphoinositide-
binding domain, which enables binding to lipids, and each
contains a clathrin-binding motif (58). One hypothesis to be
tested in the future is that Ent3p, within the TGN, causes
sorting of WT a-syn into endosomal compartments that then
transit to the vacuole for degradation. Perhaps, the same role
is played by epsinR in detoxifying human cells of WT
a-syn, i.e. epsinR causes sorting of WT a-syn into endosomal
compartments that then transit to the lysosome (mammalian
equivalent of the vacuole), where WT a-syn is degraded.
We previously identiﬁed the essential yeast gene YPP1 as a
high copy suppressor of A30P toxicity but not of WT a-syn or
A53T (22). The Ypp1 protein, when over expressed, drives
each of the three a-syns into vesicles that bud off the
plasma membrane, but only A30P-containing vesicles trafﬁc
to and merge with the vacuole, where A30P is proteolytically
degraded. We showed that Ypp1p binds to A30P but not the
other two a-syns; that YPP1 interacts with genes involved in
endocytosis/actin dynamics (SLA1, SLA2 and END3), protein
sorting (class E vps), and vesicle–vacuole fusion (MON1
and CCZ1) to dispose of A30P and that YPP1 also participates
in pheromone-triggered receptor-mediated endocytosis. We
point out that Ypp1p and Ent3p are probably cargo proteins
involved in protein transport to the vacuole but through differ-
ent pathways. Ypp1p is speciﬁc for A30P and mediates its
transport from the plasma membrane to the vacuole, whereas
Ent3p is speciﬁc for WT a-syn and mediates its transport
from the TGN to the vacuole.
WT a-syn and the inherited mutants
The ﬁve best suppressors against WT a-syn toxicity, as judged
by ROS accumulation, did not appreciably decrease the ROS
burden in cells expressing A30P or A53T (Fig. 5). This was
unexpected in that WT a-syn and A53T (but not A03P)
each appears to transit through the classical secretory
pathway en route to the plasma membrane of yeast cells
(31), and thus we had hypothesized that the genes protecting
against WT a-syn would also protect against A53T. Instead,
ARG2, ENT3, HSP82, IDP3 and JEM1 exhibit signiﬁcant pro-
tection against ROS only in cells expressing WT a-syn. One
interpretation of this ﬁnding is that WT a-syn, A53T and
perhaps even A30P cause toxicity to cells by the same mech-
anism. In this model, overexpression of any one of these ﬁve
genes inhibits ROS in cells expressing WT a-syn but not
A30P or A53T because of subtle differences between the
two mutants and the WT protein. For example, perhaps
because of structural differences in WT a-syn compared
with A53T, Ent3p sorts WT a-syn but not A53T from the
TGN into endosomes that then transit to the vacuole. The
overexpression of Ent3p would then protect cells from WT
a-syn but not the two mutants—although the mechanism by
which the three proteins cause toxicity to cells is the same.
Another interpretation is that these three a-syns cause toxicity
to cells by different mechanisms. Thus, three different diseases
would be associated with a-syn (WT, A30P or A53T), with
perhaps three different treatments. It would not be surprising
in this model that genes that protect against WT a-syn, for
example, would not protect cells from the toxicity due to
A30P or A53T.
In summary, we have identiﬁed several novel genes that in
high copy suppress the toxicity of WT a-syn in yeast cells.
Many of these genes have human orthologs. In the future,
we hope to use yeast to elucidate in more detail the pathways
available to cells to degrade WT a-syn and its inherited
mutants. Perhaps, novel small molecules can be discovered




The yeast strains used in this study were FY23 (59), KT2253
and various deletion strains from the haploid yeast deletion
collection (Table 1; Invitrogen, Carlsbad, CA, USA).
KT2253 is a meiotic spore clone from diploid strain Y23175
(60) in the BY4743 strain background; KT2253 is congenic
to the mutant and parental strains of the yeast deletion collec-
tion. Cells transformed with galactose-inducible plasmids
were pre-grown in synthetic sucrose (2% w/v) drop out
media to maintain the selection for plasmids. The medium
containing sucrose is referred to as non-inducing medium.
a-Syn expression was induced in the same drop out media
with galactose (2% w/v) replacing sucrose (61). The
medium containing galactose is referred to as inducing
medium. The various deletion strains used in this study were
cultured in non-inducing medium with selection for plasmids
supplemented with 0.4 g/l G418 (Geneticin) or inducing
media with selection for plasmids supplemented with 0.4 g/l
G418. The high copy yeast genomic library was YEp13
based (LEU2) (62). In every experiment in this study, cells
were pre-grown in non-inducing media (sucrose) with selec-
tion for plasmids to mid-log phase and then shifted to inducing
media (galactose) with selection for plasmids and induced for
3 h. In some cases, 12 h inductions were used. Cells were
grown at 308C.
Plasmids
Plasmids harboring untagged or GFP-tagged a-syn (WT,
A30P or A53T) are described elsewhere (15). Plasmids were
constructed for this study as follows. The control plasmid
pJL100 (no insert) was made by amplifying the GAL1 promo-
ter from the plasmid pHY114-WT a-syn using the forward
and reverse primers 50-TTGTCGACATGGATATCAAAAAA
GAGGA-30 and 50-GGCGCTTAAGCTTCATGAAAGTGAA
ACA-30, which contained SalI and EcoRI restriction sites,
respectively. The PCR product was subcloned into pRS313
using these same restriction sites. The plasmid pJL101 (WT
a-syn) was made by PCR amplifying the WT a-syn gene
from pHY114-WT a-syn (Table 1) using the forward and
3792 Human Molecular Genetics, 2008, Vol. 17, No. 23reverse primers 50-GTGACTAGTATGGATGTATTCATG-30
and 50-TCTCTCGAGTAAGGCTTCAGGTTCG-30, which
contained SpeI and SacI restriction sites, respectively. The
PCR product was then subcloned into these sites in the
pRS313 vector. The plasmid pJL102 (GFP) was made by
PCR amplifying the GFP gene from pHY114-WT a-syn
using the forward and reverse primers 50-TTGTCGACAT
GGATATCAAAAAAGAGGA-30 and 50-TTACCTAGGATT
AAAACAAATTGAAATTC-30, which contained SalI and
BamHI restriction sites, respectively. The PCR product was
then subcloned into the pRS313 vector using the same restric-
tion sites. The pJL103 (GFP-WT a-syn) plasmid was made by
PCR amplifying the GFP-WT-a-syn insert from pHY114
(GFP-WT a-syn) using the forward and reverse primers
50-GTGACTAGTATGGATGTATTCATG-30 and 50- TCTCT
CGAGTAAGGCT-TCAGGTTCG-30, which contained SpeI
and SacI restriction sites, respectively. The PCR product was
then subcloned into pRS313 using the same sites. The
control plasmid pJL200 (no insert) was made by digesting
the pARG2 Open Biosystems plasmid using the EagI restric-
tion enzyme (New England Biolabs, Ipswich, MA, USA);
this digestion released ARG2. The puriﬁed linear plasmid
was ligated using T4 ligase and then propagated in DH5a
according to the standard protocols (63). Sixty-six 2m plas-
mids harboring the genes of interest (see Supplementary
Material, Table S1) were purchased from Open Biosystems;
each of these plasmids was subjected to DNA sequencing at
the Iowa State University DNA facility (http://www.dna.
iastate.edu/) to verify the authenticity of the insert. Likewise,
the plasmids constructed for this study were each subjected
to DNA sequencing to verify the authenticity of the inserts.
Hydrogen peroxide-based genetic screen
Cells transformed with pTF201 (WT a-syn) and the high copy
yeast genomic library and induced with galactose were grown
to 1.5   10
7 cells/ml and then plated on SGal–Leu–Trp. A 3/
8 in. disk of sterile Whatman ﬁlter paper containing 10 ml
of 8% H2O2 was placed in the center of each plate, and
plates were incubated for 3 days. Colonies growing within
3 cm diameter from the peroxide disk were selected,
cultured overnight and the plasmid DNA was isolated and
then ampliﬁed in DH5a cells. Both strands of each protective
plasmid were sequenced. Approximately 400 plates were
screened.
Microscopy
Fluorescence microscopy was performed with an Olympus
AX70 microscope, including an Olympus UPlanFl 100 /
1.35 NA objective with Roper CoolSNAP HQ CCD camera.
The acquisition software was IPLab v.3.6 from Scanalytics
Inc. An Olympus U-MWG (510–550) ﬁlter set was used for
detecting GFP. Data were collected at room temperature.
ROS plate reader assay
A Perkin Elmer Wallac Victor
3 1420 multilabel counter was
used to screen a-syn expressing yeast cells for ROS accumu-
lation. Cells transformed with the plasmid for a-syn (WT,
A30P or A53T) were pre-grown in non-inducing media until
mid-log phase and then shifted into galactose-inducing media
and induced for 3 h. After the second hour of induction, the
DHR123 dye was added to a ﬁnal concentration of 5 mg/ml.
Prior to adding the cells to the 96-well plates, cells were
washed twice in phosphate-buffered saline (PBS), and the
assaywasconductedinPBS.Theexcitationandemissionwave-
lengths were 485 and 535 nm, respectively. The optical density
of the culture in each well was also measured at 560 nm. The
‘ROS signal’ from each well is the ratio of the ﬂuorescence
signal divided by the optical density signal, i.e. S ¼
F(535 nm)/OD(560 nm). Experiments were conducted in three
independent experiments, each in triplicate.
Western blot analysis
Western blots were conducted as described previously (15),
with minor modiﬁcations. In brief, yeast cells transformed
with plasmids for the various a-syns (pTF201-WT,
pTF202-A30P or pTF203-A53T) and the Open Biosystem
plasmid harboring the gene of interest were cultured in
non-inducing media to mid-log phase and then shifted into
inducing media for 3 h at 308C. Cells were lysed (and all sub-
sequent manipulations were carried out at ice temperature),
protease inhibitors were added and then the protein concen-
tration was determined (Bio-Rad protein assay). Samples
(80 mg/well) were subjected to SDS–PAGE and then trans-
ferred to a membrane for detection of the various a-syns.
The monoclonal antibody against human a-syn was purchased
from Cell Signaling Technologies (Beverly, MA, USA). The
monoclonal antibody against Pgk1p was purchased from Invi-
trogen. Secondary antibodies were purchased from Jackson
ImmunoResearch Laboratories, Inc (West Grove, PA, USA).
Chemoluminescence detection (GE Health Care) was used to
visualize a-syn and the loading control Pgk1p. After detecting
a-syn, the membrane was stripped of antibody and probed for
Pgk1p. Western blot analysis was repeated three times.
Statistical analysis
Figure 2 shows the effect of the identiﬁed genes on ROS
accumulation in cells expressing WT a-syn. ROS signals
from cells transformed with pTF201 (WT a-syn) and the 2m
plasmid containing the genes of interest were compared with
cells expressing WT a-syn only (pTF201), using a paired
Student’s t-test. To adjust for multiple comparisons, the
Bonferroni correction method was used, with a family-wise
error rate of 0.05 or 0.001. For example, since 66 genes
were tested, the highest accepted P-value was 7.6   10
24
(¼0.05/66) for a family error rate of 0.05 or 1.5   10
25
(¼0.001/66) for a family error rate of 0.001 (Supplementary
Material, Table S1).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG Online.
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